CHM Cannabis
Home > Boards > US OTC > Medical - Healthcare >

MediXall Group Inc. (MDXL)

MDXL RSS Feed
Add MDXL Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 5/30/2018 12:26:34 PM - Followers: 161 - Board type: Free - Posts Today: 0



MediXall Group, Inc.
(MDXL)



www.medixall.com

Medixall's mission is to revolutionize the medical/healthcare industry by improving communications; providing better technology and support services; and, enabling more efficient, cost-effective healthcare for the patient.


Medixall's vision is to transform healthcare by using new systems, processes and technology to assist Providers to be more effective; to better interact with Payers, Customers and Stakeholders. Medixall believes that technology is the path to achieving our Mission.

Our Incubator will become both a research and development company, creating its own original products and formulas, and also a repository for thousands of patents created by others, who either choose to become partners, or sell their intellectual property outright. By finding the right strategic partners, we are able to add to the company an additional layer of revenue without losing focus on its own research and specialized operations.

Once the product/service is accepted into the MediXall distribution, the Revenue Model is built around Joint Venture licensing that will generate royalty revenue, and will keep expenses and overhead down.

The Incubator’s business model is highly collaborative in which the Company will engage diagnostic products/services, medical device technologies, and pharmaceutical companies in co-development, licensing, patent extension and marketing agreements. Initially, the Company’s business model will generate revenue through

  •  * Patenting unique processes and products to protect intellectual property
     * Creating brands for marketing/manufacturing  agreements with strategic partners
     * Licensing technologies for royalty revenues.

MediXall Incubator is seeking to leverage its leadership team’s combined expertise in diagnostics, medical devices, pharmaceutical and proprietary healthcare to position the Company as a global leader in innovative medical technologies and services.
 

Key Areas that MediXall Incubator will focus on, include:

  • Innovative Healthcare Solutions – Solutions that are intended to assist physicians, hospitals, and health systems, as well as government and private sector payers, to manage treatment outcomes through a patient-centered wellness principle, centered on both improving the quality of care and providing that care in a cost effective manner.
  • Wellness – A rapidly growing trend in health care is wellness – Preventing disease from occurring in the first place. A patient’s genetic predisposition to certain disease states such as blood clotting, cardiovascular disease, how a patient metabolizes dietary fats can drive health choices that lead to improved health.
     
     

    MediXall Group, Inc. Has Hit Significant Milestones and Now is Ready to Expand

    FORT LAUDERDALE, FL., April 11, 2018 (GLOBE NEWSWIRE) -- -- MediXall Group Inc., (OTCQB: MDXL), a technology and innovation-driven organization structured to bring effective change to the U.S. Healthcare Industry, announced today that several significant milestones have been completed. Over the past year, MediXall has made significant progress on the Company’s strategic initiatives by achieving the following:

    Launched MediXall Platform
    In March 2018, we completed development of the MediXall Healthcare Marketplace and initiated a controlled launch in South Florida, specifically in the counties of Palm Beach, Broward, and Miami Dade. The South Florida launch consists of a select group of MediXall early adopters who completed the onboarding process and were approved by the credentialing committee. With MediXall’s 5,500+ registered healthcare providers continuing to complete their legal agreements and the subsequent process of credentialing, the full launch with all medical services available is on track for the second quarter of 2018.


    https://globenewswire.com/news-release/2018/04/11/1468497/0/en/MediXall-Group-Inc-Has-Hit-Significant-Milestones-and-Now-is-Ready-to-Expand.html



    MediXall Group, Inc. Announces Appointments to Medical Advisory Board
     

    Ft. Lauderdale, Fla., Feb. 01, 2018 (GLOBE NEWSWIRE) -- MediXall Group Inc., (OTCQB:MDXL), a technology and innovation-driven organization structured to bring effective change to the U.S. Healthcare Industry, is pleased to announce that the company has added three medical doctors to the Medical Advisory Board and Credentialing Committee. Dr. Winston Marshall, MD, FACC (Denison, TX), Dr. John DeLuca, MD, DC, (Palm Beach, FL), and Dr. Kenneth Janson, MD, FACS (Boca Raton, FL), are published leaders in their fields of expertise as well as practicing physicians.

    Michael Swartz, VP of Operations of MediXall Group, said, "We are assembling a team of Advisors that will guide MediXall to provide powerful solutions to the challenges experienced by practitioners, suppliers, and consumers in the Healthcare Industry. Dr. Marshall, Dr. DeLuca, and Dr. Janson are terrific individual leaders with prestigious careers and significant healthcare experience. Each will be a tremendous asset to MediXall as we continue to drive expansion in Florida, begin our nationwide roll-out, and pursue growth opportunities leveraging the strength of our Healthcare Ecosystem. We've also made it a priority to fully credential our providers to industry standards and are proud to have three world-class doctors join the team to help us deliver on this priority. We believe that our Healthcare Marketplace Platform should be no different than traditional healthcare in meeting quality of care standards set by the industry and delivering care to patients that they can trust."

    With MediXall's commitment to promoting the highest level of quality care for its users, practitioners who join the MediXaid Provider Network must undergo a rigorous process called credentialing and only upon approval by the Credentialing Committee will a provider be able to start providing services through our Healthcare Marketplace Platform. The MediXall Credentialing Committee is responsible for reviewing the qualifications of candidates for the MediXaid Provider Network. Members of the Committee hold a Review meeting monthly to evaluate new providers for approval. MediXall is committed to its credentialing and suitability screening of all practitioners on its platform. Management feels strongly this will lead to the public having total confidence when they are comparing apple to apple healthcare providers.

    Dr. Winston S. Marshall is an Interventional Cardiology Specialist in Denison, Texas. Dr. Marshall serves as Vice-President and Physician of Interventional Cardiology at Sherman Cardiovascular Care Associates. His Professional Organizations include being a Fellow, American College of Cardiology, an American College of Cardiology Member, a member of the American Medical Association, Texas Medical Association, American Society of Nuclear Cardiology, Grayson County Medical Society and the Dallas County Medical Society. He is an active staff member at the Wilson N. Jones Medical Center in Sherman, Texas where he has held Committee and Leadership Roles.

    Dr. John DeLuca is a Diplomate of the American Board of Internal Medicine and the National Board of Chiropractic Examiners, and has obtained certifications in Hyperbaric Medicine, Pain Management, Nutrition, Strength and Conditioning, and Manipulation Under Anesthesia. He is a member of the Age Management Medicine Group, the Institute of Functional Medicine, the American College for the Advancement of Medicine, Hyperbaric and Undersea Medical Society. In addition to Internal and Hyperbaric Medicine, Dr. DeLuca's professional focus includes maximizing hormone and neurological functioning, Age Management and Regenerative Medicine, Detoxification and Chelation Therapy, Sports Medicine and Weight Loss, as well as promoting Prevention through Personal Lifestyle Medicine.

    Dr. Kenneth Janson is a Fellow of the American College of Surgeons, a former US Air Force Surgeon, a Urologic Surgeon and a certified Age Management Physician. He is a member of the Board of Governors, Tulane University School of Medicine, and a frequent featured speaker at Age Management Medical Group National conferences. He has presented at the World Congress on Age Management Medicine on the topics of Decreasing the Risk of Cognitive Decline with Hormone Optimization, and Long Term Use of Testosterone: Balancing the Risks and Rewards in Patients with Cardiovascular Disease, BPH, and Prostate Cancer. Dr. Janson brings his extensive experience in clinical science and evidence-based medicine to the field of age management to provide a comprehensive treatment and prevention program to his patients.  He combines the best of traditional medicine with clinically proven, state-of-the-art methods based on the latest techniques and research.

    If you would like to preview the MediXall Healthcare Platform, please contact the company.

    About MediXall Group, Inc.

    MediXall Group is a technology and innovation-driven organization purposefully designed and structured to bring effective change to the U.S. healthcare industry that is actively trading on the OTCQB under the symbol "MDXL." The Company believes its revolutionary approach will help drive much needed change that it envisions is needed in the current healthcare system. The mission of the MediXall Group is to revolutionize the medical industry by improving communication; providing better technology and support services; and enabling more efficient, cost-effective healthcare for the consumer. By approaching the healthcare ecosystem as a whole, MediXall creates, invests and incubates companies that embody its mission statement. MediXall's first acquisition was MediXaid®, a developing cloud-based software platform that promises to revolutionize the way people purchase healthcare goods and services.

    About MediXall Healthcare Platform

    The first product MediXall is developing is the MediXall Healthcare Platform, which is on schedule for a first quarter 2018 launch. The MediXall Platform is a new generation healthcare marketplace platform to address the growing need of self-pay and high deductible consumers for greater transparency and price competition in their healthcare costs. With MediXall.com, patient/clients find price transparency and the ability to make informed choices based on price, location and schedule for requested medical products and services. In this era of rapidly increasing deductibles and healthcare costs, the cloud-based MediXall platform is designed to be transformational and disruptive to traditional methods of medical care and provisioning of medical services to the consumer.

    Safe Harbor Statement

    This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the Company's current plans and expectations, as well as future results of operations and financial condition. Specifically, the Company's ability to raise additional capital, execute its business plan and strategy, sustain or increase gross margins, achieve profitability and build shareholder value are forward looking statements. A more extensive listing of risks and factors that may affect the Company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the Company with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

     

       Contact  Michael Swartz, VP of Operations MediXall Group, Inc. Phone: (954) 908-3481 Email: mswartz@medixall.com




    MEDIXALL GROUP’S FIRST PROJECT – The MEDIXAID Platform
MediXaid, Inc., a Florida Corporation, is completing development of a new generation healthcare marketplace platform to address the growing need of self-pay and high deductible consumers for greater transparency in their healthcare costs. The MediXaid platform provides a B2C capability that brings together into a single cloud-based, patent-pending virtual marketplace the consumers of healthcare products and services with providers that compete on price, location and schedule for requested products and services. 

The MediXaid platform will afford providers the opportunity to reach a higher percentage of self-pay and high-deductible consumers greatly benefiting the providers’ practice and assuring higher cash flow through immediate payment for services.

July 06, 2017 10:25 ET

MediXall Group, Inc. Announces that its Program to Recruit Healthcare Providers to Its Network is Approaching 1,500 Registrations

FT LAUDERDALE, FL--(Marketwired - Jul 6, 2017) - MediXall Group Inc., (OTCQB: MDXL), a technology and innovation-driven organization structured to bring effective change to the U.S. healthcare industry is pleased to announce that through its program to recruit and enlist licensed and certified Diagnostic Centers, medical service, medical product providers and Physician Practices to its Member Network, over 1,000 healthcare providers have opted-in. By opting in, these healthcare providers have taken the first step into joining MediXaid and becoming an "Early Adopter" in the revolutionary MediXaid Provider Network. 

MediXall is completing development of a new generation healthcare marketplace platform to address the growing need of self-pay and high deductible consumers for greater transparency and price competition in their healthcare costs. The MediXaid platform provides a B2C capability that brings together into a single cloud-based, patent-pending virtual marketplace the consumers of healthcare products and services with providers that compete on price, location and schedule for requested products and services.

The MediXaid platform will afford providers the opportunity to reach a higher percentage of self-pay and high-deductible consumers greatly benefiting the providers' practice and assuring higher cash flow through immediate payment for services. Consumers benefit by having greater access to more affordable qualified services in their immediate area with greater transparency in the pricing among providers...

http://www.marketwired.com/press-release/medixall-group-inc-announces-that-its-program-recruit-healthcare-providers-its-network-2225157.htm

CHM Cannabis
MDXL
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#29992   MediXall Group, Inc. Launches New Flexible Patient Financing Solution KevP3301 05/30/18 12:26:34 PM
#29991   MediXall Group to Attend the HLTH: The Future JG305 05/02/18 05:06:45 PM
#29990   Press release from MDXL. JG305 03/14/18 12:09:51 PM
#29989   10-K Annual Report file 03/01/2018 JG305 03/05/18 01:13:06 PM
#29988   This needs to go to $600 for me Swimmingly 02/01/18 02:57:14 PM
#29987   MediXall Group making some good moves. JG305 02/01/18 10:28:13 AM
#29986   MediXall Group, Inc. Announces Appointments to Medical Advisory Board JG305 02/01/18 10:24:18 AM
#29985   January 16, 2018 - MediXall Group, Inc. Completes JG305 01/19/18 09:11:36 AM
#29984   MediXall Group, Inc. Completes Milestones, Looks To Launch JG305 01/19/18 09:10:15 AM
#29983   MediXall Group, Inc. Preparing to Launch MediXaid.com JG305 01/19/18 09:09:21 AM
#29982   MediXall Group, Inc. Creates Multiple Revenue Streams in JG305 01/19/18 09:08:02 AM
#29981   MDXL 10-Q is current. JG305 08/22/17 01:22:50 PM
#29980   Fort Lauderdale, FL, February 21, 2017 (Marketwired) MediXall JG305 06/06/17 12:45:32 PM
#29979   FT. LAUDERDALE, FL–(Marketwired – Mar 14, 2017) – JG305 06/06/17 12:41:31 PM
#29978   Something happening with this ticker. Anyone on this JG305 06/01/17 09:08:30 PM
#29977   Medixall - Business Overview JG305 06/01/17 09:05:59 PM
#29976   FORM 8-K JG305 06/01/17 09:01:22 PM
#29975   Been thru a couple RS's--only have a few getmoreshares 01/21/17 07:21:44 PM
#29974   Been thru a couple RS's--only have a few getmoreshares 01/21/17 07:21:44 PM
#29973   I am! Looking and buying. adijas 01/21/17 07:07:47 PM
#29972   MDXL Security Details getmoreshares 01/21/17 07:06:26 PM
#29971   interesting trading here! Guess no one is looking! getmoreshares 01/21/17 07:04:10 PM
#29970   we HAVE A TRADE! getmoreshares 01/05/17 04:11:00 PM
#29969   OTC QB http://www.otcmarkets.com/stock/MDXL/filings getmoreshares 12/21/16 11:55:42 AM
#29968   http://medixall.com/ getmoreshares 12/21/16 11:52:01 AM
#29967   MDXL Security Details getmoreshares 12/21/16 11:51:17 AM
#29966   looks like we are slowly trading with the getmoreshares 12/20/16 07:38:29 PM
#29965   will the third time be the charm??? LOL getmoreshares 12/19/16 05:23:16 PM
#29964   CRCXD changed to MDXL: Renee 12/19/16 04:06:57 PM
#29963   Continental Rail Corp. changed to MediXall Group, Inc. Renee 11/21/16 04:38:22 PM
#29962   Legal Proceedings the saint 07/03/14 11:58:06 AM
#29961   Here is a link to the pending lawsuit john dent 07/03/14 11:38:26 AM
#29960   Form S-1 PROSPECTUS CONTINENTAL RAIL CORP. bar1080 06/08/14 11:53:14 PM
#29959   "TBG Holdings Corp released the news that this bar1080 06/08/14 11:19:48 PM
#29958   Thoughts on CRCX's new dinner train business? Anyone bar1080 06/08/14 11:08:12 PM
#29957   $CRCX possible connection to $GEGP as Francis Fytton Red Lion 04/14/14 08:51:33 PM
#29956   yep, smells alright. just another 27.91 to laserhog 02/21/14 08:29:20 PM
#29955   Any new with this stock? $6 again and gkm_nz 02/21/14 01:36:29 PM
#29954   CRCX is smells like a winner kranthikumar 02/21/14 09:47:34 AM
#29953   The train is back on track. Don't miss gkm_nz 01/17/14 05:55:51 PM
#29952   We need to see some filings from the roger wilco 12/11/13 07:16:00 PM
#29951   REALLY??? Six bucks!!!! getmoreshares 12/11/13 04:44:57 PM
#29950   Riding along on the Chattanooga choo choo. $6 gkm_nz 11/01/13 02:16:17 PM
#29949   $3.00 choo choo. All aboard. I'm in the gkm_nz 10/29/13 01:51:21 PM
#29948   i guess i was just lucky............... laserhog 10/25/13 06:10:15 PM
#29947   Oh crap! I've been trumped ... :-) Sharktnk 10/25/13 04:20:13 PM
#29946   probably not i got 2 less shares than laserhog 10/25/13 04:11:20 PM
#29945   Hopefully you can recoup more than the 3 Sharktnk 10/25/13 04:07:29 PM
#29944   congrats on being able to get out, hopefully laserhog 10/25/13 03:53:31 PM
#29943   Happy to report that I just divested this Sharktnk 10/25/13 11:44:16 AM
PostSubject